2021-01-03,"b'@JRMKE3 @DynamicMec $fate @ 16-32b+ MC- no, zero chance, like never, but I hold a core so rooting for ur moon shot dream 2 come true. Truly hope u already caught a big part of the 6x run it had in 2020- if not ur showing up to a party at 2am &amp; many of us have been raging since 5 &amp; eying the door.'"
2021-01-03,"b'RT @egelandd: @JRMKE3 @DynamicMec There\xe2\x80\x99s already so much inherent risk w/bios in general- so for taking on this risk, investors better hav\xe2\x80\xa6'"
2021-01-03,"b'@egelandd @DynamicMec I disagree\xe2\x80\x94I think $FATE has the potential to increase to $200 by EoY 2021 with the right efficacy data. 2022 $300+. This technology is a game changer in terms of cell therapy administration and cost. Looking for data at ASCO! Obviously, they don\xe2\x80\x99t produce\xe2\x80\x94SP will be punished.'"
2021-01-03,"b'@JRMKE3 @DynamicMec There\xe2\x80\x99s already so much inherent risk w/bios in general- so for taking on this risk, investors better have big potential (multi-bagger). The 2020 strat: \xe2\x80\x9cbuy high &amp; buy/chase even higher\xe2\x80\x9d isn\xe2\x80\x99t sustainable imo. So no, $fate @ current levels doesn\xe2\x80\x99t meet my risk/reward profile.'"
2021-01-03,"b'@JRMKE3 @DynamicMec Just of list of cos that have likely run too far to be considered strong/highly likely M&amp;A targets. Of course anything can happen, but I was beyond happy to book my profits in $fate between 95-101. The co went 16.75 to 103 in 2020- so no, this one isn\xe2\x80\x99t a multi-bagger from here'"
2021-01-03,b'@egelandd @DynamicMec You think $FATE has run too far??? This company is just getting warmed up!'
2021-01-03,b'@DynamicMec Have pos in most bio fan favs: $dmtk $iova $asnd $bpmc $crsp $exas $fate $gh $kod $nvcr $stok &amp; while these can go higher- many have run too far for M&amp;A to make strategic + $ sense! The ones that haven\xe2\x80\x99t ran yet: $kala $gthx $kpti $evfm $chma $zgnx $fgen $onct $tril $espr $dtil'
2021-01-03,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-03,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-03,b'$JNJ Great to be invested alongside the pros at JNJ INNOVATION \n\n$FATE iPSC \xf0\x9f\x91\x8d\xf0\x9f\x8f\xbb\n$ARWR RNAi \xf0\x9f\x91\x8d\xf0\x9f\x8f\xbb\n\nBest in class technologies ready to build on the clinical successes of 2010'
2021-01-03,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-03,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-03,"b'RT @johnfheerdinkjr: ""The Amazing Market Of 2020 &amp; Happy New Year!"" RECEIVE Vista\'s FREE \'WeekEnder\' #marketinsights https://t.co/XjTWOmwQJ\xe2\x80\xa6'"
2021-01-03,"b'RT @tribepublic: ""The Amazing Market Of 2020 &amp; Happy New Year!"" RECEIVE Vista\'s FREE \'WeekEnder\' #marketinsights https://t.co/vRhYNoCm3i $T\xe2\x80\xa6'"
2021-01-03,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-03,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-03,"b'RT @VistaPResearch: ""The Amazing Market Of 2020 &amp; Happy New Year!"" RECEIVE Vista\'s FREE \'WeekEnder\' #marketinsights  $TSLA $AAPL $FATE $ATO\xe2\x80\xa6'"
2021-01-03,b'$CYDY to be featured on Mad Money with Jim Cramer next week gaining nationwide exposure\nhttps://t.co/fK8PPZ6hwp\n\n$FCB $QGEN $CLB $PES $ATOS $APOG $EXCC $EXP $FATE $KRNY $AIZP $SIMO $RRD $ZN'
2021-01-02,"b'""The Amazing Market Of 2020 &amp; Happy New Year!"" RECEIVE Vista\'s FREE \'WeekEnder\' #marketinsights https://t.co/vRhYNoCm3i $TSLA $AAPL $FATE $ATOS $INVO $PLUG $HL #investinginthefuture #stockstowatch #tradingstocks #coronavirusupdates #EV #biotech #silver #happynewyear'"
2021-01-02,"b'""The Amazing Market Of 2020 &amp; Happy New Year!"" RECEIVE Vista\'s FREE \'WeekEnder\' #marketinsights https://t.co/XjTWOmwQJp $TSLA $AAPL $FATE $ATOS $INVO $PLUG $HL #investinginthefuture #stockstowatch #tradingstocks #coronavirusupdates #EV #biotech #silver #happynewyear'"
2021-01-02,"b'""The Amazing Market Of 2020 &amp; Happy New Year!"" RECEIVE Vista\'s FREE \'WeekEnder\' #marketinsights  $TSLA $AAPL $FATE $ATOS $INVO $PLUG $HL #investinginthefuture #stockstowatch #tradingstocks #coronavirusupdates #EV #biotech #silver #happynewyear https://t.co/HeuNUV1RFg'"
2021-01-02,b'2020-12-31 Short sale volume (not short interest) for $CRBP is 46%. https://t.co/MLlCfdDLr7 $FBIO 60% $FATE 50% $XLV 60% $VKTX 62%'
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b'$FATE Weekly. Update. Was looking to play inside wk + up, but bios hit hard last wk &amp; all names listed above went inside + dn (or inside-inside red), so no alerts triggered for me. Maybe looking rev strat for next wk if bios can pull it together - that might be a stretch. https://t.co/OUzItctMCU'"
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-02,"b""Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Crispr $CRSP\n4 Twist $TWST\n5 CareDx $CDNA\n6 Iovance $IOVA\n7 Exact Science $EXAS\n8 $FATE\n9 Invitae $NVTA\n10 Personalis $PSNL\n\n(Source https://t.co/TR7bDpBOgU) https://t.co/0XVuGmHHvP"""
2021-01-02,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-01,b'RT @BigCForever: Hot ipo $bdtx trading in range..\nWillrun like $fate in 2021'
2021-01-01,"b'RT @TonyCharts: As for RS, holy cow. If you go back and look at the true winners back in April, all had great RS lines that were 99+ AND we\xe2\x80\xa6'"
2021-01-01,b'$FATE  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 383'
2021-01-01,"b'$FATE in Downtrend: its price may drop because broke its higher Bollinger Band on December 10, 2020. View odds for this and other indicators: https://t.co/iZJphwfJQ5 #FateTherapeutics #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/UckOBhteGu'"
2021-01-01,b'Hot ipo $bdtx trading in range..\nWillrun like $fate in 2021'
2021-01-01,b'$FATE https://t.co/iNRgS2qUZ2 Fate Therapeutics Inc The automated equity analyst has detected that this stock price is aligned with its true value for now and has no clear long term directional perspective #money #forex #smallbusiness'
2021-01-01,"b'As for RS, holy cow. If you go back and look at the true winners back in April, all had great RS lines that were 99+ AND were breaking out to ATHs as the market was bottoming. Some ( $DOCU &amp; $ZM) in March and others ( $FATE) during Sept/Oct. RS is king. Period.'"
2021-01-01,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-01,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-01,b'One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a lot about what themes were in style each year!\n\n$TSLA $FVRR $TWST $ENPH $PTON $MRNA $CVAC $RUN $ZM $SE $DNLI $BEAM $PDD $SI $SDGR $FATE $BILI $NARI $ALXO $NET https://t.co/ddsdxwmNtS'
2021-01-01,b'RT @_B_I_O_T_E_C_H_: Tru ist Biotech: $XBI Stocks to own into 2021\n$BTAI $ATNX $FATE $NMTR $CNST \n$QURE $REGN $SGMO $DRNA https://t.co/hexG\xe2\x80\xa6'
2021-01-01,b'RT @bill75331820: @Biotech2k1 Just curious. Why do you own both $fate and $gmda? $fate is obviously leading in modified NK (ft-516) and CAR\xe2\x80\xa6'
2021-01-01,"b'@Biotech2k1 Just curious. Why do you own both $fate and $gmda? $fate is obviously leading in modified NK (ft-516) and CAR-NK (ft-596) space while $gmda only producr non-engineered nk cells (sound old tech to me, just like yeast cell culturing). What merits do you see in $gmda?'"
2020-12-31,b'RT @jeromeleonard5: @brendan_49 I have $fate at 600$ but I also picked $fenc for 30$ this year \xf0\x9f\x98\x86'
2020-12-31,b'@brendan_49 I have $fate at 600$ but I also picked $fenc for 30$ this year \xf0\x9f\x98\x86'
2020-12-31,"b'Stocks with greater movement, last 15 minutes\n\n$MVIS +/- 1.71% MicroVision Inc.\n$CRSP +/- 1.34% CRISPR Therapeutics AG\n$NLS +/- 1.04% Nautilus Inc.\n$FATE +/- 1.01% Fate Therapeutics Inc.\n$FCEL +/- 0.77% FuelCell Energy Inc.\nhttps://t.co/GKZO0ovKj9'"
2020-12-31,"b'RT @pawcio2009: This is it Ladies and Gentlemen, one more day, one last lap, perhaps one final Hail Mary? #biopick2020 concludes tomorrow.\xe2\x80\xa6'"
2020-12-31,b'RT @TopStockTips1: $ACST shorts getting squeezed bottom is in at the 20 moving average .29 cents\n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT\xe2\x80\xa6'
2020-12-31,"b'RT @TahoeLK: @avidresearch $TGTX my top MA candidate, I would add $FATE but current valuation is high for M&amp;A; but in general I dont think\xe2\x80\xa6'"
2020-12-31,b'RT @Dadbod4evah: @biostockguru $fate \n$250\n#2021biobuyout'
2020-12-31,b'@biostockguru $fate \n$250\n#2021biobuyout'
2020-12-31,"b'RT @TahoeLK: @avidresearch $TGTX my top MA candidate, I would add $FATE but current valuation is high for M&amp;A; but in general I dont think\xe2\x80\xa6'"
2020-12-31,"b'RT @pawcio2009: This is it Ladies and Gentlemen, one more day, one last lap, perhaps one final Hail Mary? #biopick2020 concludes tomorrow.\xe2\x80\xa6'"
2020-12-31,"b'This is it Ladies and Gentlemen, one more day, one last lap, perhaps one final Hail Mary? #biopick2020 concludes tomorrow. Here is where we stand on the biotech race. Perhaps the only fight is for 3rd between $ocul and $cydy? $fate and $tgtx looks like have too much work to do. https://t.co/fNjkTlyrkX'"
2020-12-31,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat\n\nInside D Add's .... None!\n\n3-1 D... $TVTX $SWKS $COHR $AOSL $LMPX $INMD $KRNT $EXPO\xe2\x80\xa6"""
2020-12-31,"b'Tomrrow\xe2\x80\x99s #watchlist for #NYSE, #NASDAQ between $90 and $100: $AMD $ATHM $BILI $BLL $CHWY $DUK $FATE $FSLY $ITRI $KMX $LOGI $NTES $NVS $PLD $SYNA'"
2020-12-31,b'$arkg dec 29 to dec 30 change in shares held:\n\n$accd 2.94%\n$adpt 2.94%\n$aqb 0.00% \xf0\x9f\x90\x9f\xf0\x9f\xa5\xb6\n$arct uq 0.00%\n$beam 2.94%\n$bli 2.94%\n$cdna 2.94%\n$cdxs 2.94%\n$cers 0.00%\n$cgen 0.00%\n$clls 0.00%\n$crsp 0.00%\n$cstl 2.94%\n$edit 0.00%\n$evgn 0.00%\n$exas 2.94%\n$fate 2.94%'
2020-12-30,"b""Hit em if you want em! #TheStrat\n\nInside D Add's .... None!\n\n3-1 D... $TVTX $SWKS $COHR $AOSL $LMPX $INMD $KRNT $EXPO $KSU $ROCK $POWI $QTRX $PRAX $CYBR $SEAS $ACA\n\nRev. Strat D... $GOCO $SGTX $MODN\n\nATR over 5 ($20-100) w/Inside D... $BLI $NKTX $CERT $FATE $BIGC $EXPI $PENN https://t.co/bTFwU8S3Kx"""
2020-12-30,b'RT @biostonks: Gene tx players 1-10B mkt cap $NTRA $NVTA $ARWR $FATE $BBIO $IOVA $EDIT $PTCT $PACB $ALLO $NTLA $CDNA $ALKS $RCKT $NSTG $BLU\xe2\x80\xa6'
2020-12-30,"b'@avidresearch $TGTX my top MA candidate, I would add $FATE but current valuation is high for M&amp;A; but in general I dont think we will see any M&amp;A before JPM. There were also high expectations last year but nothing happened... hope to be wrong'"
2020-12-30,"b'RT @Biotech2k1: In Biotech, Winners keep winning while laggards; well, linger. Just look at 5 year charts of $SGMO +97% vs $CRSP +937% or $\xe2\x80\xa6'"
2020-12-30,"b'In Biotech, Winners keep winning while laggards; well, linger. Just look at 5 year charts of $SGMO +97% vs $CRSP +937% or $NK -7.9% vs $FATE +2820%. Maybe at the track you can bet $10 on the 40 to 1 horse, but in biotech the winners run circles around the laggards.'"
2020-12-30,"b""Here's a Cancer-Killing Stock to Buy for 2021 @themotleyfool #stocks $NK $FATE https://t.co/DmE0diRM3g"""
2020-12-30,b'Gene tx players 1-10B mkt cap $NTRA $NVTA $ARWR $FATE $BBIO $IOVA $EDIT $PTCT $PACB $ALLO $NTLA $CDNA $ALKS $RCKT $NSTG $BLUE $AGIO $ARCT $SGMO $SRNE $PGEN $RGNX $QURE $DRNA $MYGN $ADVM $FLGT $CLLS $KRYS $PASG\nfeel free to give input https://t.co/ln7esOVk86'
2020-12-30,b'RT @TopStockTips1: $ACST shorts getting squeezed bottom is in at the 20 moving average .29 cents\n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT\xe2\x80\xa6'
2020-12-30,"b'Stocks with greater movement, last 15 minutes\n\n$AMRN +/- 1.17% Amarin Corporation plc\n$FATE +/- 0.85% Fate Therapeutics Inc.\n$ALNY +/- 0.84% Alnylam Pharmaceuticals Inc.\n$GE +/- 0.61% General Electric Company\n$MRNA +/- 0.57% Moderna Inc.\nhttps://t.co/9y1n8hqFPP'"
2020-12-30,"b""$FATE $NK $IBRX Here's a Cancer-Killing Stock to Buy for 2021 @themotleyfool #stocks $NK $FATE https://t.co/9Kh2CCJK1y"""
2020-12-30,b'$ACST shorts getting squeezed bottom is in at the 20 moving average .29 cents\n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT $SECI $FUBO $AQMS $IPOC $EQOS https://t.co/OLtA0PEJ54'
2020-12-30,b'$MRNA $RARE $MRSN $FATE $NTLA 5 Biotech Stocks That Have Gained More Than 200% in 2020 https://t.co/wKpu9eJfTk'
2020-12-30,"b'$FATE. Recent moves in $ARCT should be a wakeup call for $FATE. I originally entered at 35 and love the story and company for long term. But a near term deep correction ~60 is probable. Worst case takes us into the 40s, but first wait to see what price does at the gap. $ARKG https://t.co/9XP6fU4Oy2'"
2020-12-30,b'https://t.co/iNRgS2qUZ2 Fate Therapeutics Inc Our AI assessed the market value of this company is aligned with its true value for now and is neither a long or short opportunity in the longer term $FATE #investing #realestate #smallbusiness'
2020-12-29,b'$arkg dec 28 to dec 29 change in shares held:\n\n$accd 1.20%\n$adpt 1.20%\n$aqb 1.20%\n$arct uq 0.00%\n$beam 10.91% \xf0\x9f\x94\xa5\n$bli 6.74% \xf0\x9f\x91\x80\n$cdna 1.20%\n$cdxs 1.20%\n$cers 0.00%\n$cgen 0.00%\n$clls 0.00%\n$crsp 0.00%\n$cstl 4.22%\n$edit 0.00%\n$evgn 0.00%\n$exas 1.20%\n$fate 1.20%'
2020-12-29,"b'RT @JRMKE3: @sbarnettARK Simon, It would be great if you could do a podcast with Scott Wolchko or Dan Shoemaker of $FATE. Disclaimer: I am\xe2\x80\xa6'"
2020-12-29,"b'$FATE - already expensive and will only get pricier. hnCD16 data at ASH derisks the entire pipeline; huge optionality in r/r settings and earlier line combos. iPSCs are ultimate CTx modality. Despite the price tag, wouldn\xe2\x80\x99t be surprised to see this one taken off the board in 2021'"
2020-12-29,b'5 Biotech Stocks That Have Gained More Than 200% in 2020. $MRNA $FATE $RARE $NTLA $MRSN https://t.co/qbtoeyPflG'
2020-12-29,"b'@sbarnettARK Simon, It would be great if you could do a podcast with Scott Wolchko or Dan Shoemaker of $FATE. Disclaimer: I am very long FATE, but I find most people have no idea what the hell FATE is doing, which is a shame!!! If they can get to commercialization\xe2\x80\x94it will be a paradigm shift.'"
2020-12-29,b'RT @TopStockAlerts1: 5 Biotech Stocks That Have Gained More Than 200% in 2020\n\n$RARE $MRSN $IBB $FATE $MRNA \n https://t.co/9lItX0d0Tm'
2020-12-29,b'RT @TopStockAlerts1: 5 Biotech Stocks That Have Gained More Than 200% in 2020\n\n$RARE $MRSN $IBB $FATE $MRNA \n https://t.co/9lItX0d0Tm'
2020-12-29,b'5 Biotech Stocks That Have Gained More Than 200% in 2020\n\n$RARE $MRSN $IBB $FATE $MRNA \n https://t.co/9lItX0d0Tm'
2020-12-29,b'@Xecuter2 Okay! After 4+ years I think I know how this trades. If you think $FATE is going to give up much more than it already has\xe2\x80\x94you have another thing coming. I actually prefer the current consolidation phase we are experiencing. This will be trading at $100-105 by the end of January.'
2020-12-29,b'@Xecuter2 And now $FATE is down 3%! As someone who has been with this company for over four years\xe2\x80\x94this action happens once every 8 weeks or so and quickly recovers intraday or within 3-4 trading days. You don\xe2\x80\x99t get a lot of time to make a move and accumulate on the downside.'
2020-12-29,b'$SING We are implementing and executing on deliberate and sound fundamental strategies to position SinglePoint for a move to a listed exchange.\n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $TSLA'
2020-12-29,b'12:03:57 PM DREV Manual Exit.  Closing my $FATE position of 279 shares that was opened today for a 5.08% gain.'
2020-12-29,b'Stopped out of $QS (+2.78R) $XNCR (-0.23R) $CRSP (+2R) $GNRC (+1.5R) $FATE (-0.05R) $EMR (-0.59R) $WD (+0.26R)'
2020-12-29,b'$XBI Five names trading strong in a still very red tape; $AUPH $VBIV $BYSI $MYOV. $FATE may follow them soon\xf0\x9f\xa4\x9e'
2020-12-29,b'RT @TopStockTips1: $SING Direct Solar America; the Rise of Singlepoint Inc(OTCMKTS:SING) | Micro Cap Daily #SOLAR #solarenergy #renewableen\xe2\x80\xa6'
2020-12-29,"b'REVERSALtoDOWN: $FATE Fate Therapeutics, Inc https://t.co/pd0C7a2K8A \xf0\x9f\x93\x89 \xf0\x9f\x94\x9c TradeIdeas via \xe2\x9f\xb6 https://t.co/ZgCyz4rX3x'"
2020-12-29,b'Added a bit of $FATE and $ARWR'
2020-12-29,b'10:01:22 AM DREV Automated Entry.  Long 279 shares of $FATE at 89.56 for a trade that I will be looking to close today.'
2020-12-29,"b'Like I said, $FATE $EDIT $NTLA $PACB all got 15+% haircuts today, more to come.'"
2020-12-29,b'Gene therapy / gene editing stocks on sale today with rest of biotech. $edit $fate $sgmo $crsp $ntla'
2020-12-29,b'$EDIT -15%\n$BEAM -12%\n$ALXO -8%\n$SYRS -13%\n$FATE -7%\n$ATNM -25%'
2020-12-29,b'RT @TopStockTips1: $SING Direct Solar America; the Rise of Singlepoint Inc(OTCMKTS:SING) | Micro Cap Daily #SOLAR #solarenergy #renewableen\xe2\x80\xa6'
2020-12-29,b'RT @TopStockTips1: $SING Direct Solar America; the Rise of Singlepoint Inc(OTCMKTS:SING) | Micro Cap Daily #SOLAR #solarenergy #renewableen\xe2\x80\xa6'
2020-12-29,b'$SING Direct Solar America; the Rise of Singlepoint Inc(OTCMKTS:SING) | Micro Cap Daily #SOLAR #solarenergy #renewableenergy \n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO https://t.co/s8cp5mOaTB'
2020-12-29,b'#ARK_W10 (2)\n$LGVW +14.8\n$INCY +14.8\n$PSTI +14.8\n$ACCD +14.8\n$CDNA +14.8\n$CDXS +14.8\n$ADPT +14.8\n$AQB +14.8\n$FATE +14.8\n$PHR +14.8\n$SDGR +14.8\n$CRWD \xe2\x88\x9214.1\n$4477 +13.6\n$TDOC +13.2\n$MKTX +12.5\n$4689 +12.4\n$8473 +12.4'
2020-12-29,"b'RT @MingJong: For full HD (1080) watch the video ""Top 9 BEST Performing BIOTECHNOLOGY US Stocks - $MRNA, $TWST, $MCRB, $FATE, $RARE, $PACB,\xe2\x80\xa6'"
2020-12-29,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-29,b'RT @ileff: $arkg dec 24 to dec 28 change in shares held:\n\n$accd 3.68%\n$adpt 3.68%\n$aqb 3.68%\n$arct uq 0.00%\n$beam 7.10% \xf0\x9f\x91\x80\n$bli 3.68%\n$cdna\xe2\x80\xa6'
2020-12-29,b'$arkg dec 24 to dec 28 change in shares held:\n\n$accd 3.68%\n$adpt 3.68%\n$aqb 3.68%\n$arct uq 0.00%\n$beam 7.10% \xf0\x9f\x91\x80\n$bli 3.68%\n$cdna 3.68%\n$cdxs 3.68%\n$cers 0.00%\n$cgen 0.00%\n$clls 0.00%\n$crsp 0.00%\n$cstl 4.92%\n$edit 0.00%\n$evgn 0.00%\n$exas 3.68%\n$fate 3.68%'
2020-12-29,"b'$FATE Fate Therapeutics, Inc. - Top stock up 484% from low. Close: 96.21 VolvsAvg: 0.60 Liq: $66M https://t.co/MDvZ4cvDIr'"
2020-12-28,b'$FATE $ARKG ARK added 99K shares of FATE today\xe2\x80\x942.777M total.'
2020-12-28,b'RT @TopStockTips1: $SING looks like 004 test is coming some big buys \n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTE\xe2\x80\xa6'
2020-12-28,b'4% losers after hours or more\n$ACST\n$AEMD\n$ALT\n$APEN\n$ATHE\n$AUTL\n$BLU\n$BNGO\n$CLIX\n$CNTY\n$EMAN\n$ETB\n$EYES\n$FATE\n$FEDU\n$GNPX\n$JAGX\n$KFFB\n$MYSZ\n$OGEN\n$ORGO\n$RHE\n$RVSB\n$SD\n$SGH\n$SIMS\n$SQFT\n$STAF\n$URG\n$VISL\n$WNW'
2020-12-28,b'$SING looks like 004 test is coming some big buys \n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT $SECI $FUBO $AQMS $IPOC $EQOS https://t.co/khnl74bvjL'
2020-12-28,b'RT @_B_I_O_T_E_C_H_: Barcl. $XBI Biotech M&amp;A Scenario analysis shows:\n\n$KPTI upside to M&amp;A  269% or $56\n\nnext in line $EPZM .... $FATE ....\xe2\x80\xa6'
2020-12-28,"b""$SING super thin to the 004s now selling drying up mm's moving up \n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT $SECI $FUBO $AQMS $IPOC $EQOS https://t.co/hwGvuZqbN8"""
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat \n\nInside D Add's... $ALLK $ENPH $BEAM $CCCC $RUN $WMG $CSII $BE $BRBR $AOSL $SWBI $YE\xe2\x80\xa6"""
2020-12-28,b'RT @PatternProfits: @TrendSpider Ditto for $FATE. 30 min chart here. Hat tip to @harrypearce101 on this one. On strength only. Chart courte\xe2\x80\xa6'
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat \n\nInside D Add's... $PBW $LUNG $WGO* $BLNK $SAIL $TPGY* $MAX $CSII $DAC $SHAK $MSP* $\xe2\x80\xa6"""
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat\n\nInside D Add's... $KOD $CYRX $IRBT $NTGR $WLL $CNNE* $LL\n\n3-1 D... $POST $BECN $NTCT\xe2\x80\xa6"""
2020-12-28,b'Watching $FATE-- tight price action &amp; high short interest. #biotech #swingtrading'
2020-12-28,b'$SING 3.7 mill in bids now 0035-0036 ready to move back up \n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT $SECI $FUBO $AQMS $IPOC $EQOS https://t.co/7k2tPKSf1I'
2020-12-28,b'$SING .0035 new bottom just needs some volume to get back into the 004s \n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT $SECI $FUBO $AQMS $IPOC $EQOS https://t.co/is18idMDlT'
2020-12-28,b'$SING SinglePoint Inc. (OTC:SING) Improves Balance Sheet by Eliminating Convertible Secured Note Agreement \n\n$KODK $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT $SECI $FUBO $AQMS $IPOC $EQOS $ACST $XL $GHIV\n\nhttps://t.co/oilqxM05Tm'
2020-12-28,b'$SING We are implementing and executing on deliberate and sound fundamental strategies to position SinglePoint for a move to a listed exchange.\n\n$KODK $VLDR $PFE $SUMO $ROKU $SPCE $MSFT $CVM $IPOC $GHIV $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $TSLA'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'@TahoeLK Do you have a new target for $FATE ?'
2020-12-28,"b""With $FATE hitting $100 last week, the only remaining was $MYOV which should break $30 with today's partnership news. $TGTX https://t.co/Ey5wcLT8c2"""
2020-12-28,"b'RT @Kevin_W81: $FATE \n\nASH Conference updates gains\n\n+42% December 19, 2019 \n+37% December 7, 2020'"
2020-12-28,"b'RT @TomSilver39: Barclays:"" SCENARIO ANALYSIS OF M&amp;A VALUATIONS FOR Barclays COVERAGE: $KPTI, $EPZM, $EXEL, $AGIO, $RCUS, $DCPH, $CTMX, $NK\xe2\x80\xa6'"
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'$FATE 500 million cash'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'@JRMKE3 Why don\xe2\x80\x99t you think $FATE is a good target? Seems like many BPs would be interested.'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-28,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-27,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-27,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-27,"b'RT @johnfheerdinkjr: ""The Russell 2000 &amp; Apple\xe2\x80\x99s Electric Car Efforts Created Value During This Holiday Shortened Trading Week"" RECEIVE Vis\xe2\x80\xa6'"
2020-12-27,"b'RT @tribepublic: ""The Russell 2000 &amp; Apple\xe2\x80\x99s Electric Car Efforts Created Value During This Holiday Shortened Trading Week"" RECEIVE Vista\'s\xe2\x80\xa6'"
2020-12-27,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-27,"b'RT @VistaPResearch: ""The Russell 2000 &amp; Apple\xe2\x80\x99s Electric Car Efforts Created Value During This Holiday Shortened Trading Week"" RECEIVE Vist\xe2\x80\xa6'"
2020-12-27,b'RT @RichardMoglen: Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retwe\xe2\x80\xa6'
2020-12-27,b'Focus List for this Week \xf0\x9f\x9a\x8012-27-2020 #RMWL\n\n$FATE $FCX $FROG $LRCX $MED $MU $NARI $NIO $PLTR $RXT $UPWK\n\n\xf0\x9f\x91\x8dLike and Retweet! \xf0\x9f\x94\x81\n\n\xe2\x96\xb6\xef\xb8\x8fFundamental and Technical Analysis + Setups\n\nhttps://t.co/nwYCSeu4JH'
2020-12-27,b'RT @JRMKE3: $FATE My PT\xe2\x80\x99s 2021/2022: $175/250+ respectively! Been right the last four years and I don\xe2\x80\x99t expect anything different the next\xe2\x80\xa6'
2020-12-27,"b'@JRMKE3 To be honest, I think your 2021 PT is a little low...!\nPositive 2021 data flow will IMHO drive $FATE SP above $225 ...!'"
2020-12-27,b'$FATE My PT\xe2\x80\x99s 2021/2022: $175/250+ respectively! Been right the last four years and I don\xe2\x80\x99t expect anything different the next two. Don\xe2\x80\x99t trade this equity\xe2\x80\x94buy and hold!'
2020-12-27,"b'RT @johnfheerdinkjr: ""The Russell 2000 &amp; Apple\xe2\x80\x99s Electric Car Efforts Created Value During This Holiday Shortened Trading Week"" RECEIVE Vis\xe2\x80\xa6'"
2020-12-27,b'Watchlist for tomorrow: $SIF $XL $STIC $FATE $ADXN $AIRT $LAZR https://t.co/b9Jo2zWWrh'
2020-12-27,b'@AdamShipwreck @bradloncar @adamfeuerstein @STL_Biotech @AndyBiotech @biotequity @BiotechWorld A company like $FATE has the potential to be Genentech of the past - likely a few years from a substantial revolution in programmable cellular therapeutics (and with the current lead).'
2020-12-27,b'RT @DKellerCMT: Top ten ranked stocks in our SCTR Mid Cap model are up an average of 490% in 2020.  Year end is a perfect to ask questions\xe2\x80\xa6'
2020-12-27,b'$FATE https://t.co/iNRgS2qUZ2 Fate Therapeutics Inc The mathematical model is forecasting that this stock price will fall in the short term and has no ground to be a long term opportunity #business #stockmarket #trader'
2020-12-27,b'RT @wyv_123: Will we see another biotech buyout this year? $MREO $CRIS $ONCT $SGMO $EDIT $FATE $NTLA $TRIL'
2020-12-27,b'RT @infinitum_cm: @ARKInvest $ARKG Genomics ETF top holdings: $PACB $CRSP $ARCT $TWST $NVTA $TDOC $PSNL $CDNA $FATE $EXAS #Genomics #scienc\xe2\x80\xa6'
2020-12-27,b'@ARKInvest $ARKG Genomics ETF top holdings: $PACB $CRSP $ARCT $TWST $NVTA $TDOC $PSNL $CDNA $FATE $EXAS #Genomics #science #innovation #StocksToWatch #daytrading #investing https://t.co/3PfZocKrEp'
2020-12-27,"b'RT @KermitCapital: Today Ark Invest\n\nBought:\n$IOVA, $22.6M\n$NVS, $18.1M\n$REGN, $15.2M\n$VRTX, $12.3M\n$U, $12.2M \xf0\x9f\x9a\xa8\n$RHHBY, $12.1M\n$SURF, $8.6\xe2\x80\xa6'"
2020-12-27,"b'RT @jeremymday: A Thread on the Top 10 holdings of $ARKG\n\nOne quick comment on each company, what they do, and how scalable they are for in\xe2\x80\xa6'"
2020-12-27,"b'RT @jeremymday: A Thread on the Top 10 holdings of $ARKG\n\nOne quick comment on each company, what they do, and how scalable they are for in\xe2\x80\xa6'"
2020-12-27,"b'RT @KaraniBwenge: This new decade Biotech is going to build amazing momentum!\nFrom Gene editing, cell therapy to biologics manufacturing\nIt\xe2\x80\xa6'"
2020-12-27,"b'RT @Biotech2k1: Winning in biotech is about discovering companies like $CRSP, $FATE, $IOVA and $BEAM before the crowd stampedes into them a\xe2\x80\xa6'"
2020-12-27,"b'RT @KaraniBwenge: This new decade Biotech is going to build amazing momentum!\nFrom Gene editing, cell therapy to biologics manufacturing\nIt\xe2\x80\xa6'"
2020-12-27,b'RT @Biotech2k1: New top Science Ideas:\n\n1. mRNA\n2. CRISPR\n3. KRAS\n4. iPSC\n5. NK cells\n6. CD-47\n\nNew top 10 Companies:\n\n1. $FATE\n2. $BEAM\n3.\xe2\x80\xa6'
2020-12-27,b'RT @Biotech2k1: New top Science Ideas:\n\n1. mRNA\n2. CRISPR\n3. KRAS\n4. iPSC\n5. NK cells\n6. CD-47\n\nNew top 10 Companies:\n\n1. $FATE\n2. $BEAM\n3.\xe2\x80\xa6'
2020-12-27,b'RT @Biotech2k1: New top Science Ideas:\n\n1. mRNA\n2. CRISPR\n3. KRAS\n4. iPSC\n5. NK cells\n6. CD-47\n\nNew top 10 Companies:\n\n1. $FATE\n2. $BEAM\n3.\xe2\x80\xa6'
2020-12-27,"b'RT @larrywabrams: @Keith_Wasserman $FATE donor master NK iPSC is a once a decade biotech breakthrough similar to mAB in 1990s.  Affordable,\xe2\x80\xa6'"
2020-12-27,b'RT @Biotech2k1: New top Science Ideas:\n\n1. mRNA\n2. CRISPR\n3. KRAS\n4. iPSC\n5. NK cells\n6. CD-47\n\nNew top 10 Companies:\n\n1. $FATE\n2. $BEAM\n3.\xe2\x80\xa6'
2020-12-27,"b'RT @VistaPResearch: ""The Russell 2000 &amp; Apple\xe2\x80\x99s Electric Car Efforts Created Value During This Holiday Shortened Trading Week"" RECEIVE Vist\xe2\x80\xa6'"
2020-12-27,"b'RT @johnfheerdinkjr: ""The Russell 2000 &amp; Apple\xe2\x80\x99s Electric Car Efforts Created Value During This Holiday Shortened Trading Week"" RECEIVE Vis\xe2\x80\xa6'"
2020-12-27,"b""RT @ChartsLeto: Lot's of powerplays folks.. $FATE is setting up for a breakout into ATH.. It has all the components.. +118% in price run an\xe2\x80\xa6"""
2020-12-27,b'@wyv_123 You can take $FATE off that list because it will never happen.'
2020-12-27,"b'RT @larrywabrams: @Keith_Wasserman $FATE donor master NK iPSC is a once a decade biotech breakthrough similar to mAB in 1990s.  Affordable,\xe2\x80\xa6'"
2020-12-27,b'Will we see another biotech buyout this year? $MREO $CRIS $ONCT $SGMO $EDIT $FATE $NTLA $TRIL'
2020-12-27,"b'@jeremymday I just gave it a listen. The analyst did a admirable job but made many mistakes. One: $FATE does not have 14 product candidates. He kept mentioning that and it isn\xe2\x80\x99t true. They have at least a dozen \xe2\x80\x9carms\xe2\x80\x9d spread out over five IPSC candidates\xe2\x80\x94FT500, FT516, FT596, FT538, FT819.'"
2021-01-08,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-08,b'$fate vs $arct\nHigher or Lower\n\nwow what a day for Arcturus up 35%\nFate pulling him up 20% himself https://t.co/RblClAVBof'
2021-01-08,b'RT @ToddWilliamson: $pgen has prof of concept. $fate does not. $pgen less than 2 billion market cap. $fate 10 billion. $pgen can make cart\xe2\x80\xa6'
2021-01-08,b'Top 15 Pharmaceuticals stocks with market cap over 1 billion today. \n\nhttps://t.co/baRNPvx22K\n\n$ARCT $CRSP $FATE $CVAC $PACB $NTLA $NRIX $BTAI $COHR $EDIT $VCEL $RETA $NK $ALNY $AMRN\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/c80hQsKkDg'
2021-01-08,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-08,b'Top 15 Pharmaceuticals stocks with market cap over 1 billion in 5 days. \n\nhttps://t.co/baRNPvx22K\n\n$ARCT $NTLA $IMAB $FATE $PACB $CVAC $ALGS $MYGN $CRSP $SWAV $EDIT $RYTM $TEVA $PCRX $TRIL\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/eWvudH6rls'
2021-01-08,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-08,b'RT @RNAiAnalyst: $AFMD AFM24-NKMax NK most likely to get us close to $FATE-type valuation. AFM24 mono worth the shot.'
2021-01-08,"b""@DrPaulyDeSantis @JRMKE3 Do you have concerns in ipsc's  safety? How long will  $fate nk stay in the body?  https://t.co/Wmk46oVTOT"""
2021-01-08,b'$arkg jan 06 to jan 07 change in shares held:\n\n$accd 1.64%\n$adpt 1.53%\n$aqb 0.00%\n$arct uq 0.00%\n$beam 1.53%\n$bli 10.83% \xf0\x9f\x94\xa5\n$cdna 1.53%\n$cdxs 1.53%\n$cers 0.00%\n$cgen 0.00%\n$clls 0.00%\n$crsp -0.80%\n$cstl 1.53%\n$edit 0.00%\n$evgn 0.00%\n$exas 1.53%\n$fate 1.53%'
2021-01-08,b'Short sale vol (not short interest) for $TQQQ on 2021-01-06 is 52%. https://t.co/UQjPxOnBSE $ARRY 50% $FATE 44% $PEP 47% $SPSB 46%'
2021-01-08,b'#ARK_WD5_1721 (1.7.21 vs 1.6.21) (1)\n\n$NTLA +0.099\n$TCEHY \xe2\x88\x920.098\n$FATE +0.093\n$NSTG \xe2\x88\x920.079\n$ZM \xe2\x88\x920.075\n$SQ \xe2\x88\x920.075\n$TXG +0.065\n$ICE \xe2\x88\x920.06\n$NTDOY \xe2\x88\x920.058'
2021-01-08,"b'$FATE Fate Therapeutics, Inc. - #Monster #Volume #Stock $SPY $SPX $QQQ 117.22 VolvsAvg: 2.12 Liq: $274M https://t.co/MDvZ4cvDIr'"
2021-01-07,b'@KermitCapital also a $24.9m $fate buy yesterday'
2021-01-07,b'Scan results - Expansion Breakout today: $DDD $NCTY $SSYS $ANGO $PECK $MSTR $MARA $AMSC $SWIR $PLUG $NOVS $DAC $RIOT $LMND $COLL $CRSP $STZ $FATE $VALE $TPH ... https://t.co/3JfP9F0MF9'
2021-01-07,"b'$FATE Fate Therapeutics, Inc. SEC Filing: Form 424B5 https://t.co/rq3SxadZ7u'"
2021-01-07,b'$FATE / Fate Therapeutics files form 424B5 https://t.co/3zm0SL9R4h'
2021-01-07,b'(3 of 6)\nSoftware: +5.50%; 66 of 67 Up (&gt;=8%: $VERI $RIOT $MTLS $AI $NETE $CLSK $MSTR $CRNC)\nBio/Pharm: +5.40%; 61 of 67 Up (&gt;=8%: $AQB $CRSP $FATE $NTLA $BEAM $EDIT $DMTK $VCEL $MDXG $NK $TWST $CRDF $AFMD $EVGN $DNLI $TFFP)'
2021-01-07,"b'Big moves in $FATE, $LMND, $FCEL and $NIO today with a few others that had decent moves'"
2021-01-07,b'Oversold: $NFLX $SJM $RDY $BYND $HUYA $VIRT $MRSN $FLWS $DUG $SOXS\n\nOverbought: $CI $NET $BMRN $FATE $EXEL $GLUU $TEF $GWRE $RL $RETA $LXRX $PZD $FAS $KORU $VOT\n\nMomentum: $SCHW $PPG $ULTA $VALE $HDB $TXG $PLUG $FSLR $TTEK $EDIT $CNQ $LAZ $CLF $FLGT $REMX $SLX $SMOG $TAN $YOLO'
2021-01-07,"b""$CRSP $EDIT $BEAM $NTLA $FATE Wow so amazing with these biotech stocks!  Who doesn't want to cash out today?  Let wait until tomorrow!"""
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'Large Print $FATE Size: 292412 Price: 117.22 Time: 1600 Amount: $34,276,534.64'"
2021-01-07,b'Sold $bdtx\n\nFeels #re***d buying $bdtx instead of $fate around 6 months back\n\xf0\x9f\x99\x87'
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'We have identified an unusual $FATE block that expires on January 15, 2021 with a strike price of $130.00.\n\n7,850 CALL contracts with a price of $0.85 were purchased at a $667,250 premium.'"
2021-01-07,b'RT @OnlyBios: $ADAP should be trading $10+ look at the $FATE valuation'
2021-01-07,"b'$LMND $FATE $SIG and $AQB my ONH list, @AOTtrades @gvstrader'"
2021-01-07,b'$pgen has prof of concept. $fate does not. $pgen less than 2 billion market cap. $fate 10 billion. $pgen can make cart cells in 11 minutes and last in patients 7 months plus and no Lypodepletion. $pgen works on solid tumors.'
2021-01-07,b'#Genetics stocks pop after $NTLA offers update for gene-editing drugs. $CRSP $EDIT $BEAM $FATE #stocks #investingnews #biotech https://t.co/CItv1Dld4o'
2021-01-07,b'$ADAP should be trading $10+ look at the $FATE valuation'
2021-01-07,b'@LuoshengPeng Fabulous.  Take a look at $FATE\n33% move in two days.'
2021-01-07,"b'For Biotech, trying to stick to 2 names.\n\nSome starters got thrown out end of year\n\nDid a 3rd buy point into $FATE yesterday. This has now become a sizable position\n\n2nd name will be revealed once position becomes full. It\xe2\x80\x99s also my stock pick for 2021 in a stock picking contest!'"
2021-01-07,"b'@JRMKE3 $FATE needs to achieve 50%+ CR rate to compete with CD20xCD3 bispecifics, and auto-CAR T....arguably their true competitor is donor-derived allo-CAR T, and bar for success is lower in that case probably 30% CR rate.'"
2021-01-07,"b'@DrPaulyDeSantis If anything, $FATE has been selecting most of their patients in their trials that have failed many previous therapies and are very sick individuals.'"
2021-01-07,"b""@HawkStocks @AOTtrades $FATE up over 17%, wish i would've taken. But can't predict the future"""
2021-01-07,b'RT @DrPaulyDeSantis: For the CAR-T folk out there. $FATE now is at $JUNO takeover valuation ~$10B and could reach $KITE soon at this rate.\xe2\x80\xa6'
2021-01-07,"b'Probably the most important reason $NK @NantKwest has not had a parabolic rise like $FATE is lack of strong and unquestionably DATA. I REPEAT DATA DATA DATA.  On a more positive note, if the PANCREATIC CANCER DATA update by @hoaghealth is solid. $NK will take off.'"
2021-01-07,b'$FATE Idea: how about some of you really smart people with MD and PhD in front of your names stop looking at FATE through the prism of being a straight NK/T cell play? The use of IPSC\xe2\x80\x99s allows this company to armor their tech and dramatically reduce cost to current therapies.'
2021-01-07,b'@DrPaulyDeSantis Lamest post of 2021 $Fate'
2021-01-07,"b""My report card for 2H20 (performance from date of Tweet to today):\n\n$FATE : +272% \xf0\x9f\x94\xa5\xf0\x9f\x94\xa5\xf0\x9f\x94\xa5\n$BTAI : +18% \n$KNSA: -6%\n$TRIL: +127% \xf0\x9f\x94\xa5\xf0\x9f\x94\xa5\n\nI'll give myself a B+. Top picks for 1H21 will be posting after JPMorgan Conference next week...stay tuned! https://t.co/gY6bkREutz"""
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'@DrPaulyDeSantis Further, let\xe2\x80\x99s say $FATE can only get their cost down to $1250 per dose and they require two three-week (one dose per week) cycles for treatment\xe2\x80\x94six doses at $1250 = $7500. They could mark it up to $50K (margins) and still reduce total cost from CAR-T by 10X.'"
2021-01-07,b'RT @RNAiAnalyst: $AFMD AFM24-NKMax NK most likely to get us close to $FATE-type valuation. AFM24 mono worth the shot. https://t.co/3umKmJ4d\xe2\x80\xa6'
2021-01-07,b'@DrPaulyDeSantis Current CAR-T therapies can cost up to 500K per patient over a years worth of treatments. $FATE can produce in a GMP manufacturing run ($1M\xe2\x80\x94 ~300 doses @ $2500 per dose). They aren\xe2\x80\x99t even remotely close to scaling. What do you think will happen when they get there? $500-$1K dose.'
2021-01-07,"b'$FATE soaked up that 4.4M share secondary at 85.5 with ease, already up 30% since!'"
2021-01-07,b'Almost cashed in $FATE at $100 last week but decided to hold a little longer... so seeing today it is trading at $116... that\xe2\x80\x99s kind of like #FATE right?'
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,b'Kicking myself for cancelling that stop limit buy on $FATE a couple days ago. \xf0\x9f\xa4\xa6\xe2\x80\x8d\xe2\x99\x82\xef\xb8\x8f AND selling $TAN yesterday'
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,"b'Call me crazy, but it would appear as though there is/was just a TINY bit of pent up demand for $FATE.'"
2021-01-07,b'https://t.co/GxBRd4lkKB\n\n2021-JAN-07 1:30pm\n$FATE #FateThx Fate up 15.98% = $1.2 billion gain.\n\n(Jan 06) Photo: Polls close in a runoff that will decide the fate of the Senate - Los Angeles Times https://t.co/vFCRvojCzf'
2021-01-07,"b'@MichaelodwyerMD If $FATE succeeds then its justified, but the risk is high up here! But iPSCs \xf0\x9f\xa7\xab &gt;&gt;&gt; \xf0\x9f\xa7\x91\xe2\x80\x8d\xe2\x9a\x95\xef\xb8\x8f\xf0\x9f\x92\x89DONOR-DERIVED allo anything....\xf0\x9f\x93\x9b'"
2021-01-07,"b'$CRSP $EDIT $BEAM $NTLA $FATE Don\'t forget the Name of the Game ""Biotech Stock"" Easy money comes, easy money goes!'"
2021-01-07,b'RT @chiragontwtr: $fate moving like no tomorrow..'
2021-01-07,b'RT @DrPaulyDeSantis: For the CAR-T folk out there. $FATE now is at $JUNO takeover valuation ~$10B and could reach $KITE soon at this rate.\xe2\x80\xa6'
2021-01-07,b'$fate moving like no tomorrow..'
2021-01-07,b'RT @DrPaulyDeSantis: For the CAR-T folk out there. $FATE now is at $JUNO takeover valuation ~$10B and could reach $KITE soon at this rate.\xe2\x80\xa6'
2021-01-07,b'@jablamsky Nice move for $BTAI-congrats.  When biotech stocks gain momentum they can move fast.  Put $FATE on your radar.  Great company with awesome management team.'
2021-01-07,"b'Other fun #biotech news today: Gene-editing stocks are flying. The only news I see is an update from $NTLA on its programs, including plans for its ATTR treatment. Others rising include $CRSP, $EDIT, $BEAM and $FATE.'"
2021-01-07,b'RT @RNAiAnalyst: $AFMD AFM24-NKMax NK most likely to get us close to $FATE-type valuation. AFM24 mono worth the shot.'
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,"b'@adamfeuerstein @bradloncar To be clear, F\'N\' Becca is an acronym.\n\n$FATE $NTLA $BEAM $EDIT $CRSP  $CVAC  $ARCT\n\n""How are your returns?"" ""Great, I just bought F\'n\' Becca.""\n\n(Or you, know, terrible, depending on the time period. Not making a prediction here.)'"
2021-01-07,b'For the CAR-T folk out there. $FATE now is at $JUNO takeover valuation ~$10B and could reach $KITE soon at this rate. All on &lt;5 patients worth of data and probability of success &lt;30% at this point vs &gt;50-100 pts worth of data with $JUNO and $KITE \xf0\x9f\x92\xa1 THINK about that\xf0\x9f\xa4\x94 #TcellRx'
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,b'$AFMD $FATE let strike a partnership at JP Morgan 2021 \xf0\x9f\x92\xaa https://t.co/P9vN4RED88'
2021-01-07,b'$FATE is this making a multi year defining move right now?'
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,b'Big Gainer Alert: Trading today\xe2\x80\x99s 12.9% move in FATE THERAPEUTICS INC. COMMON\xc2\xa0$FATE https://t.co/zJg6svDudP'
2021-01-07,"b'$FATE $CRSP $BLUE $EDIT $NTLA $BEAM Look like the market rally today might be faked and will selloff later!  Watch out biotech investors.  If you can get a free Tesla car today, go ahead and do it fast!'"
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,b'@adamfeuerstein @bradloncar Thank you. Identify great science early =&gt; large investment returns. $FATE'
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,"b'RT @adamfeuerstein: It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" li\xe2\x80\xa6'"
2021-01-07,"b'It\'s a buoyant day for mRNA-NKcell-genomeediting stocks $ARCT $CRSP $NTLA $FATE $CVAC $EDIT $BEAM\n\nWe need a ""FAANG"" like acronym. @bradloncar suggestions?'"
2021-01-07,b'(3 of 5)\nChina: +4.55%; 23 of 27 Up (&gt;=10%: $CBAT $CAN $NIU)\nTelcom/Elctrn: +4.33%; 32 of 37 Up (&gt;=10%: $CBAT $NNDM $CAN $MVIS $DM)\nBio/Pharm: +4.19%; 61 of 67 Up (&gt;=10%: $CRSP $NTLA $FATE $AQB $EDIT $BEAM $DMTK)\nFinance: +4.04%; 14 of 16 Up (&gt;=10%: $MOGO $UPST)'
2021-01-07,b'$MDGEF $MDG1.DE #TCR T-cell therapy up &gt;20% today\n\nThis might be the year of T-cells as well as NK-cells but definitely immune therapies in #solid tumours https://t.co/X2gtPb2oPf\n\ncc $ADAP $ALLO $BNTX $BLCM $BLUE $CLLS $CYAD $FATE $IMTX'
2021-01-07,"b'Next generation biotech platform leader:\n\n5)New Cell therapy: $FATE, $ALLO, $ALLO, $AFMD, $TCRR\n6)Antibody engineering: $SGEN, $RGEN, $GMAB,$YMAB, $ARGX $ZYME, $BCYC, $XNCR, $MGNX\n7) Kinase Inhibitor: $MRTX, $TPTX, $DCPH, $RLAY, $PRLD; $RVMD; $BDTX; $PMVP;$SDGR'"
2021-01-07,b'$FATE rolled half to FEB 80/105'
2021-01-07,b'$FATE  new high  $NTLA new high $NIU new high'
2021-01-07,b'@JRMKE3 @JoeySolitro $FATE up 26% in 2 days!'
2021-01-07,b'$FATE new high....   see this stuff is easy.... your job is just to train your eyes to recognize what is bullish (this applies for swing n day trades)  ...  day trading is so easy when u master this'
2021-01-07,b'$FATE Again up big...currently $110 \xf0\x9f\xa4\x91\xf0\x9f\xa4\x91\xf0\x9f\xa4\x91 #stockstowatch'
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,b'RT @RNAiAnalyst: $AFMD AFM24-NKMax NK most likely to get us close to $FATE-type valuation. AFM24 mono worth the shot.'
2021-01-07,b'$FATE having a wonderful year still!!!'
2021-01-07,b'$ADAP has lot of catching up to do to get some of that $FATE kind of valuation'
2021-01-07,b'$FATE $NTLA have really good patterns....  its really unfortunate they have wide bid ask'
2021-01-07,b'@Biotech2k1 Another 10% up for $fate with no news today. Crazy market.'
2021-01-07,b'$FATE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/zdVGqKifTS #FateTherapeutics #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yNX1UFMQcr'
2021-01-07,b'$FATE $NTLA   what am thinking  the bid ask is ridiculous   wingnuts'
2021-01-07,b'Thanks $FATE'
2021-01-07,b'If I were forced to pick CRSP companies - valuations are excessive - $NTLA - in vivo gene editing platform to the liver\nhttps://t.co/HnzK0rb9aO\n$EDIT - licensed iPCS tech from Bluerock for cancer prior to Bayer buyout (have $FATE capabilities)\nhttps://t.co/GaCq2UzM5Y'
2021-01-07,b'RT @RNAiAnalyst: $AFMD AFM24-NKMax NK most likely to get us close to $FATE-type valuation. AFM24 mono worth the shot. https://t.co/3umKmJ4d\xe2\x80\xa6'
2021-01-07,b'RT @princetongb: @bradloncar Lots of chatter $FATE and #JPM2021. Not many folks big enough to take them out - so perhaps lots of deal makin\xe2\x80\xa6'
2021-01-07,b'@bradloncar Lots of chatter $FATE and #JPM2021. Not many folks big enough to take them out - so perhaps lots of deal making in their future. Many catalysts this year.'
2021-01-07,b'$ISR with this huge FDA NEWS $3 break is eminent but what if it breaks $15?\xf0\x9f\x92\xb8\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $DPLO $THO $JT $JNJ $PFE $LLY $MRK $ROKU $TSLA $FB $MU $SIRI $SPY $UBER $AMZN $JPM #CRYPTO #BITCOIN $F $C https://t.co/uO0IYlTUyz'
2021-01-07,b'New 52 Week High today: $FRC $TGT $MS $WCC $DAR $BBL $TSM $DE $BLK $FATE $ENS $WMS $BYD $RF $COF $CLF $MTZ $WK $VSTO $GS ... https://t.co/4Iw0QeR3p8'
2021-01-07,b'$FATE'
2021-01-07,"b""$FATE on Today's US Breakout Focus List \n\nCharging Out \xf0\x9f\x93\x88\n\n#stockstowatch #stockstotrade #trading https://t.co/osPSalmmg3"""
2021-01-07,"b'#ARKK also just entered a \xf0\x9f\x9f\xa2$25 million\xf0\x9f\x9f\xa2 position on Fate Therapeutics $FATE, a clinical-stage biopharm company using cell-based immunotherapies against cancer &amp; immune disorders. \xf0\x9f\xa7\xab https://t.co/y47qk1HQLg'"
2021-01-07,b'$FATE beautiful continuation from last nights list of stocks to watch https://t.co/oxEQh1TGaT https://t.co/gy3JATv1PR'
2021-01-07,b'$NTLA $FATE  both on my screen....but not enough hands... missed BO move'
2021-01-07,b'$ISR NEWS!!! GONNA break $2 today!\xe2\x9c\x88\xf0\x9f\x8d\xbe\xf0\x9f\x92\xb8\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $DPLO $THO $JT $JNJ $PFE $LLY $MRK $ROKU $TSLA $FB $MU $SIRI $SPY $UBER $AMZN $JPM #CRYPTO #BLOCKCHAIN #ICO #BITCOIN $FNMA $DRYS $AMD $F $M https://t.co/wGoLzoXMPh'
2021-01-07,"b'$FATE announced offering @ $85 yesterday, now $105\nIncredible institutional demand'"
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,b'$FATE $8.7B valuation versus  $AFMD $580M leaves a lot of MC potential of 14x. https://t.co/Yx6snOCS7q'
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b""@JRMKE3 @cscarroll @liorsela Here's ARK's daily position size for $FATE, going back 2 months... https://t.co/Hf1OqViHhY"""
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,b'$FATE premarket https://t.co/LHJNl9BH9e https://t.co/nCt0OAoCG2'
2021-01-07,"b'The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells:  $FATE $AFMD $GMDA $NKTX\n\nCheckpoints:  $TRIL $ALXO $IMAB $STTK $CRIS (?)'"
2021-01-07,b'@JRMKE3 @Joshuatrader1 @liorsela Do you follow the ishares Genomics ETF as well?  Smaller than ARKG but also has sizable stake in $FATE and its currently the largest position https://t.co/LkoohjBznN'
2021-01-07,b'@Joshuatrader1 @cscarroll @liorsela 2.995M of $FATE in $ARKG (doubled their position from 3Q to 4Q) and started a 250K position in $ARKK. 3.25M total.'
2021-01-07,b'$AFMD AFM24-NKMax NK most likely to get us close to $FATE-type valuation. AFM24 mono worth the shot. https://t.co/3umKmJ4do3'
2021-01-07,b'@Joshuatrader1 @cscarroll @liorsela I follow ARK relative to $FATE! They are deliberately leaving FATE off their daily emails. I have watched day after day of accumulation by checking their fund holdings religiously. They don\xe2\x80\x99t want to overtly tell everyone they are accumulating.'
2021-01-07,b'@Joshuatrader1 @liorsela Thanks...that makes your updates that much more valuable!  I misspoke...it appears they have $FATE in $ARKG but this was a new buy in $ARKK \xf0\x9f\x91\x80 \n\nAppreciate all your hard work \xf0\x9f\x91\x8d\xf0\x9f\x8f\xbb'
2021-01-07,"b""@cscarroll @liorsela The email that ARK sends out is only a partial list of trades that they do in a day.  They do not include rebalancing type trades in the email, so that's the main difference.  Occasionally there are big differences like $FATE (I didn't even realize it wasn't on yesterday's email)"""
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'#FateTherapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants $FATE https://t.co/XCfbITAXrJ'
2021-01-07,b'RT @AimHardy: #MXCT\n\nI believe MaxCyte is on the Same trajectory as Fate Therapeutics $FATE.\n\nThis is where I believe we are in the cycle o\xe2\x80\xa6'
2021-01-07,b'@Joshuatrader1 @liorsela What is the difference between the full report and the email? The email for example didn\xe2\x80\x99t even include $FATE. Interestingly they did actually hold it until they sold their position on 12/17/20. It is also the largest position in the iShares Genomics ETF https://t.co/cJbJZ7K1Sh'
2021-01-07,b'$FATE UP'
2021-01-07,b'RT @mandriao84_: #ARK_WD10_1621 (1.6.21 vs 12.30.20)\n\n$TSLA +0.561\n$NTLA +0.221\n$TXG +0.199\n$GBTC +0.191\n$U \xe2\x88\x920.174\n$TDOC +0.157\n$EXAS \xe2\x88\x920.13\xe2\x80\xa6'
2021-01-07,b'#ARK_WD10_1621 (1.6.21 vs 12.30.20)\n\n$TSLA +0.561\n$NTLA +0.221\n$TXG +0.199\n$GBTC +0.191\n$U \xe2\x88\x920.174\n$TDOC +0.157\n$EXAS \xe2\x88\x920.134\n$SQ +0.134\n$FATE +0.133\n$PSNL \xe2\x88\x920.114\n$REGN +0.112\n$ZM +0.112\n$PACB +0.107'
2021-01-07,b'RT @ShiftTrading: Ark Invest Full Trading Map for 2021-01-07\n$TSLA (+17m)\n$BLI (+13m)\n$TDOC (+12m)\n$RHHBY (+11m)\n$TWST (+11m)\n$ROKU (+10m)\xe2\x80\xa6'
2021-01-07,b'RT @ShiftTrading: Ark Invest Full Trading Map for 2021-01-07\n$TSLA (+17m)\n$BLI (+13m)\n$TDOC (+12m)\n$RHHBY (+11m)\n$TWST (+11m)\n$ROKU (+10m)\xe2\x80\xa6'
2021-01-07,b'Fate Therapeutics Inc. Shares Close the Day 15.1% Higher - Daily Wrap https://t.co/gWGK8Oyjxo $FATE #stockmarket #kwhenfinance'
2021-01-07,b'Fate Therapeutics Inc. Shares Near 52-Week High - Market Mover https://t.co/lH1xxurhVp $FATE #stockmarket #kwhenfinance'
2021-01-07,b'Ark Invest Full Trading Map for 2021-01-07\n$TSLA (+17m)\n$BLI (+13m)\n$TDOC (+12m)\n$RHHBY (+11m)\n$TWST (+11m)\n$ROKU (+10m)\n$SQ (+8m)\n$CDNA (+7m)\n$FATE (+7m)\n$IOVA (+7m)\n\n$ARKG $ARKW $ARKF $ARKK https://t.co/MykX46X0pV'
2021-01-07,"b'$FATE Fate Therapeutics, Inc. - Top stock up 484% from low. Close: 99.78 VolvsAvg: 3.31 Liq: $316M https://t.co/MDvZ4cvDIr'"
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'BREAKING NEWS: $FATE Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants https://t.co/S0xXkkuoHp\n    \n#NXTNYE @youyou00181002 $NCTY $DTMXF $ISR $GTCH'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith - Sorted by % Volume Increase [+461] \xf0\x9f\x94\xa5\n\nA key part of our process in ident\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,"b'Wed (1/6/21) highest % above the opening 30-min high, G/L % in final 30-Min &amp; Trading range % (Min $5, Vol 750K, Opt Vol in any strike 500): $NCTY $WBAI $CBAT $X $ACMR $CLSK $SWBI $FATE $VRAY $PERI $NEP $VSTO $AAOI $RVLV $WW $TCS $MSTR $CYTK $CVM $IOVA $GVA $NVAX $SUNW $SFIX $GPS https://t.co/1w2yxQIYHz'"
2021-01-07,b'RT @wyzzil: $FATE $TXG ARK was busy spending \xf0\x9f\x92\xb0. Their two largest capital injections today. Both newly added to ARKK (already found in ARKG\xe2\x80\xa6'
2021-01-07,"b'$FATE $TXG ARK was busy spending \xf0\x9f\x92\xb0. Their two largest capital injections today. Both newly added to ARKK (already found in ARKG). \xf0\x9f\x91\x80\n\nShares added to ARKK:\nFATE 250,000 shares added\nTXG  511, 016 shares added \n\nThe change in share totals from below were added to ARKG. https://t.co/LWLP4nS4GJ'"
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'Oversold: $NVDA $CRM $MA $COUP $BYND $IRTC $BAND $AMOM\n\nOverbought: $BP $OXY $FATE $HE $IBTX $PAA $MIC $CHIM\n\nMomentum: $TGT $BIO $HES $MTZ $XEC $CLF $WMB $MSTR $TSE $XME'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong 21ema support bounces. Biotech back in a big way as flags b/o; $DMTK $RDUS $NTLA $FATE $RGNX. Solar hot again too. Personal screen generated through @MarketSmith https://t.co/7ovWHjdFpX'
2021-01-07,b'RT @Biotech2k1: I set up go to complete exit orders for 6 of my companies that I deem reached fairy tale valuations.\n\n1. $TPTX out at $130\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: @Pharmdca I got a fair value for $TRIL at $20.81 with my valuation model. I have been buying it as one of the only cheap bi\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: Updated my Top 10 list after selling my #1 pick with $FATE. I replaced it with $GBIO which I think could be a game changer.\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: I set up go to complete exit orders for 6 of my companies that I deem reached fairy tale valuations.\n\n1. $TPTX out at $130\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: @Pharmdca I got a fair value for $TRIL at $20.81 with my valuation model. I have been buying it as one of the only cheap bi\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: Updated my Top 10 list after selling my #1 pick with $FATE. I replaced it with $GBIO which I think could be a game changer.\xe2\x80\xa6'
2021-01-07,b'RT @JRMKE3: $FATE $ARKK ARK started a 250K position in their innovation fund. Almost 3.25M shares between $ARKK and $ARKG.'
2021-01-07,b'RT @JRMKE3: $FATE $ARKK ARK started a 250K position in their innovation fund. Almost 3.25M shares between $ARKK and $ARKG.'
2021-01-07,"b'I still plenty of healthy charts like $ROKU $FATE $CARR $ADSK. These stocks are approaching low risk buy points. Im thrilled to re-buy or start new positions tomorrow, so I can sleep well tonight. \n\nTomorrows a new day, be dumb, follow price.'"
2021-01-07,b'@Biotech2k1 Congrats on a great trade. What are your thoughts on $GMDA as a 2021-2022 replacement for $FATE?'
2021-01-07,b'Top 15 Pharmaceuticals stocks with market cap over 1 billion today. \n\nhttps://t.co/hVOwcz0PBt\n\n$FATE $KURA $NTLA $RGNX $EPZM $RYTM $CYTK $ALGS $MYGN $MRNA $NVAX $XNCR $FOLD $TBIO $REPL\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/iGugDaj75m'
2021-01-07,b'$FATE $ARKK ARK started a 250K position in their innovation fund. Almost 3.25M shares between $ARKK and $ARKG.'
2021-01-07,"b'RT @Joshuatrader1: ARK Invest, Cathie Wood, trading activity for 1/6/2021:\n$ARKK $ARKQ $ARKW $ARKG $ARKF\n\nNo email received yet, so posting\xe2\x80\xa6'"
2021-01-07,"b'RT @Joshuatrader1: ARK Invest, Cathie Wood, trading activity for 1/6/2021:\n$ARKK $ARKQ $ARKW $ARKG $ARKF\n\nNo email received yet, so posting\xe2\x80\xa6'"
2021-01-07,b'RT @Biotech2k1: Updated my Top 10 list after selling my #1 pick with $FATE. I replaced it with $GBIO which I think could be a game changer.\xe2\x80\xa6'
2021-01-07,"b'RT @Joshuatrader1: ARK Invest, Cathie Wood, trading activity for 1/6/2021:\n$ARKK $ARKQ $ARKW $ARKG $ARKF\n\nNo email received yet, so posting\xe2\x80\xa6'"
2021-01-07,"b'ARK Invest, Cathie Wood, trading activity for 1/6/2021:\n$ARKK $ARKQ $ARKW $ARKG $ARKF\n\nNo email received yet, so posting the full list of trades using the holdings reports.\n\nNew Buy(s): $TXG $FATE\nSignificant Buy(s): $BLI\nSignificant Sell(s): None\n\n1 of 7 https://t.co/I9nRK1SxKJ'"
2021-01-07,"b'@Biotech2k1 they might have literally bought your shares. they started a 250,00 shares position of $fate in $arkk today'"
2021-01-07,b'two new positions for $arkk today $txg $71.6m and $fate 24.9m'
2021-01-06,b'$arkg jan 05 to jan 06 change in shares held:\n\n$accd 2.53%\n$adpt 2.53%\n$aqb 0.00%\n$arct uq 0.00%\n$beam 2.53%\n$bli 10.22% \xf0\x9f\x94\xa5\n$cdna 2.53%\n$cdxs 2.53%\n$cers 0.00%\n$cgen 0.00%\n$clls 0.00%\n$crsp 0.00%\n$cstl 2.53%\n$edit 0.00%\n$evgn 0.00%\n$exas 2.53%\n$fate 2.53%'
2021-01-06,"b'$FATE Fate Therapeutics, Inc. - #Monster #Volume #Stock $SPY $SPX $QQQ 99.78 VolvsAvg: 3.31 Liq: $316M https://t.co/MDvZ4cvDIr'"
2021-01-06,"b'@Biotech2k1 Interesting, do you think $FATE is overextended here?'"
2021-01-06,b'Updated my Top 10 list after selling my #1 pick with $FATE. I replaced it with $GBIO which I think could be a game changer. They have targeted LNP vectors which can be dosed over and over again for gene therapies. These are truly life long therapies now.'
2021-01-06,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith - Sorted by % Volume Increase [+461] \xf0\x9f\x94\xa5\n\nA key part of our process in ident\xe2\x80\xa6'
2021-01-06,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith - Sorted by % Volume Increase [+461] \xf0\x9f\x94\xa5\n\nA key part of our process in ident\xe2\x80\xa6'
2021-01-06,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith - Sorted by % Volume Increase [+461] \xf0\x9f\x94\xa5\n\nA key part of our process in ident\xe2\x80\xa6'
2021-01-06,"b'Daily Up on Volume scan powered by @MarketSmith - Sorted by % Volume Increase [+461] \xf0\x9f\x94\xa5\n\nA key part of our process in identifying emerging themes, gauging risk appetite, and generating ideas.\n\nStandouts\n$SWBI\n$FATE\n$RUN\n\n#IBDPartner https://t.co/ZAY6Nu2F9R'"
2021-01-06,b'$FATE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/BP9ui0rdYb #FateTherapeutics #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MyDtUpdnJK'
2021-01-06,b'(3 of 5)\nBio/Pharm: +2.17%; 47 of 67 Up (&gt;=8%: $ONVO $FATE $CGC $NTLA $DMTK)\nMaterials: +2.06%; 13 of 21 Up (&gt;=8%: $AMRS $LAC $RYAM)\nRetail: +1.53%; 26 of 43 Up (&gt;=8%: $TCS $GPI $GRWG $BOOT $ZUMZ $BGFV)\nConsumer: +1.50%; 28 of 42 Up (&gt;=8%: $VOXX $VFF $TUP)'
2021-01-06,b'$ISR MASSIVE FDA NEWS gonna break $3\xf0\x9f\x92\xb8\xf0\x9f\x93\x88\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $DPLO $THO $JT $JNJ $PFE $LLY $MRK $ROKU $TSLA $FB $MU $SIRI $SPY $UBER $AMZN $JPM #CRYPTO #BLOCKCHAIN #ICO #BITCOIN $FNMA $DRYS $AMD $F $M https://t.co/V5Wh7mxJ5W'
2021-01-06,b'$ISR MASSIVE FDA NEWS bouncing aftethours\xf0\x9f\x92\xb8\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $DPLO $THO $JT $JNJ $PFE $LLY $MRK $ROKU $TSLA $FB $MU $SIRI $SPY $UBER $AMZN $JPM #CRYPTO #BLOCKCHAIN #ICO #BITCOIN $FNMA $DRYS $AMD $F $M https://t.co/vhD9RC80mm'
2021-01-06,b'Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants        \n\nAnyone ever seen pre-funded warrants before?\n\nNew one for me\n\n$FATE\n                         https://t.co/1Rdz2SmORD via @UnhedgedApp'
2021-01-06,"b""@HawkStocks @AOTtrades $FATE and $MTZ are the two I like but didn't take a position in either due to washington issues."""
2021-01-06,"b""RT @Biotech2k1: I don't make the crazy money like 800% by chasing funds like ARK. I make that return because I find companies like $FATE, $\xe2\x80\xa6"""
2021-01-06,"b'Large Print $FATE Size: 291994 Price: 99.78 Time: 1600 Amount: $29,135,161.32'"
2021-01-06,b'Today\xe2\x80\x99s price action $FATE vs $NK UNBELIEVABLE!  @NantKwest  @immunitybio @DrPatSoonShiong https://t.co/204CoIF0QP'
2021-01-06,"b'RT @VistaPResearch: ""Markets Swing Soundly Into The Green On Tuesday"" RECEIVE Vista\'s FREE \'Daily Market Insights\'  $TSLA $JAGX $ATOS $INVO\xe2\x80\xa6'"
2021-01-06,"b'Stocks to Watch Tomorrow Jan 6, 2021\n\n$SPG\n$XPO\n$TXG\n$FATE\n\nhttps://t.co/2Azt3jNq2j'"
2021-01-06,b'https://t.co/GxBRd4lkKB\n\n2021-JAN-06 2:30pm\n$FATE #FateThx Fate up 14.63% = $1.1 billion gain.\n\n(Jan 06) Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire https://t.co/Bo4A35pIDq'
2021-01-06,"b'Well $FATE hit $100, and thanks to the protest idiots in DC, knocked it under $100 https://t.co/ayeVw4zxcS'"
2021-01-06,b'$FATE This is working nicely'
2021-01-06,"b'What to take to time to say a fond farewell to my top pick for 3 years with $FATE. My sale to liquidate the last of my position just triggered at $100.00. That is an 800% return in 3 years. I love the company, but its priced for perfection and its a very lock road to commercial.'"
2021-01-06,b'$FATE share price increases 15.0%. See recent news release. https://t.co/dcFoPfTizp'
2021-01-06,b'Where is money flowing today? $CHNG $SPWR $X $REGI $DY $QS $CRON $SUM $RUN $FCEL $ENPH $FATE $UPST $CGC $M $PACW $CADE $SEDG $RLJ $APHA $ROCK $AHCO $ARRY $CLG $ACA $PLUG $GRWG $AUB $ZION https://t.co/4kEHAGJfur'
2021-01-06,b'$FATE https://t.co/zCp1lfHmJx'
2021-01-06,b'Let\xe2\x80\x99s hit $100 again please $FATE'
2021-01-06,b'@TeddyCleps $hate $fate'
2021-01-06,b'$FATE Fate Therapeutics Announces Pricing Of 4.4 Million Shares At $85.50 Per Share https://t.co/mGXk2YTEdy'
2021-01-06,b'$FATE https://t.co/2MrQ1fYcaW'
2021-01-06,b'$ISR here comes that 1.60 BREAK! MINI-ME shorts are about to get FRIED\xf0\x9f\x94\xa5 Its going viral!! $10 break in days VERY POSSIBLE. Did u guys even digest the FDA NEWS? DID U??! LMFAOOOOO\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $c https://t.co/UlNJmPOo4m'
2021-01-06,"b'$FATE announced the pricing of an underwritten public offering of 4,421,053 shares of its common stock at a public offering price of $85.50 per share. Stock soars +14.26% https://t.co/YkHDfPKV8W'"
2021-01-06,"b""RT @StockMKTNewz: Top 10 holdings of Cathie Wood &amp; Ark Invest's $ARKG Genomic Rev ETF as of 12/31\n\n1 Pacific Bio $PACB\n2 Teladoc $TDOC\n3 Cr\xe2\x80\xa6"""
2021-01-06,"b""RT @Biotech2k1: I don't make the crazy money like 800% by chasing funds like ARK. I make that return because I find companies like $FATE, $\xe2\x80\xa6"""
2021-01-06,b'$ISR with this huge FDA NEWS $3 break is eminent but what if it breaks $15?\xf0\x9f\x92\xb8\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $DPLO $THO $JT $JNJ $PFE $LLY $MRK $ROKU $TSLA $FB $MU $SIRI $SPY $UBER $AMZN $JPM #CRYPTO #BITCOIN $F $C https://t.co/uO0IYlTUyz'
2021-01-06,b'RT @AimHardy: #MXCT\n\nI believe MaxCyte is on the Same trajectory as Fate Therapeutics $FATE.\n\nThis is where I believe we are in the cycle o\xe2\x80\xa6'
2021-01-06,"b'@Pharmdca I got a fair value for $TRIL at $20.81 with my valuation model. I have been buying it as one of the only cheap biotechs left. Maybe its my next $FATE, $CRSP or $BEAM as I am preparing to sell those as they are fully played out and then some.'"
2021-01-06,b'RT @AimHardy: #MXCT\n\nI believe MaxCyte is on the Same trajectory as Fate Therapeutics $FATE.\n\nThis is where I believe we are in the cycle o\xe2\x80\xa6'
2021-01-06,"b""I don't make the crazy money like 800% by chasing funds like ARK. I make that return because I find companies like $FATE, $CRSP, $BEAM, $IOVA, $TPTX and $MRTX before anyone even knows they exist. Now, I get to sell them to someone like ARK for 800% premium and go find the next."""
2021-01-06,b'$FATE IS A BEAST'
2021-01-06,b'$FATE up $12 even w/ a Public Offering \xf0\x9f\x92\xaa https://t.co/r2mjRiXFfJ'
2021-01-06,"b""I was trying to retweet my tweet the other day about expecting $FATE to drop then rally post secondary pricing... It's uncanny how often you can buy the drop on a secondary in biotech."""
2021-01-06,b'StockTwits Trending Alert: Trading recent interest in FATE THERAPEUTICS INC. COMMON\xc2\xa0$FATE https://t.co/vk7RQKl4QY'
2021-01-06,"b""RT @dhovekamp42: $FATE Surges More Than 152% in Three Months: Here's Why?  \n(spoiler it is related to iPSC-derived immune cells)\n| NASDAQ h\xe2\x80\xa6"""
2021-01-06,"b'RT @PersimmonTI: $FATE\n\nSecondary considerations:\n\n- Strong pricing, at $85.50\n\n- Upsized; $400mm against initial $350mm\n\n- $60mm greenshoe\xe2\x80\xa6'"
2021-01-06,b'(2 of 4)\nSemis: +4.13%; 33 of 44 Up (&gt;=10%: $SPWR $SOL $BEEM $ENPH $CSIQ)\nBlockChain: +3.47%; 11 of 18 Up (&gt;=10%: $CLSK $MARA)\nConsumer: +3.37%; 34 of 42 Up (&gt;=10%: $QS $VOXX $VFF)\nBio/Pharm: +3.36%; 58 of 67 Up (&gt;=10%: $ONVO $CGC $FATE $NTLA $CMPS)'
2021-01-06,b'#MXCT\n\nI believe MaxCyte is on the Same trajectory as Fate Therapeutics $FATE.\n\nThis is where I believe we are in the cycle of MaxCytes growth in comparison to Fate \n\nOnly the Start \xf0\x9f\xa5\x87 https://t.co/7og21GPwgq'
2021-01-06,"b""$FATE Surges More Than 152% in Three Months: Here's Why?  \n(spoiler it is related to iPSC-derived immune cells)\n| NASDAQ https://t.co/4sLkOIVP3g"""
2021-01-06,b'@LuoshengPeng like $fate...   crazy town'
2021-01-06,b'$FATE up $10 ...this stock has been great \xf0\x9f\x91\x8d 2X in 6 months !! #Biotech'
2021-01-06,b'I set up go to complete exit orders for 6 of my companies that I deem reached fairy tale valuations.\n\n1. $TPTX out at $130\n2. $MRTX out at $235\n3. $IOVA out at $50\n4. $FATE out at $100\n5. $CRSP out at $175\n6. $BEAM out at $100\n\nBeen a good run with mega profits from 200% to 800%'
2021-01-06,b'$FATE really strong after that offering.'
2021-01-06,"b""@bradloncar It's $FATE."""
2021-01-06,"b'@Biotech2k1 Is it a bubble? I believe some new investors learnt via $MRNA $CRSP $FATE ,... that this risky new Biotech can be disrupting. The bio\xe2\x80\x98s were dead since 2016. And now a new trend is started. Like $AAPL $FB $NVDA ,... 30% correction are part of a trend'"
2021-01-06,"b""$FATE\n\nSo far, Mr. Market saying mo' shares, less problems... https://t.co/OIIw1jMw30"""
2021-01-06,"b'RT @IOInvestors: Early premarket gappers \n\nGapping up:  \n\n$CHNG +37.7%, $CALM +8.2%, $CHU +4.4%, $WFC +2.9%, $PAC +2.8%, $CHL +2.4%, $ACMR\xe2\x80\xa6'"
2021-01-06,"b'Early premarket gappers \n\nGapping up:  \n\n$CHNG +37.7%, $CALM +8.2%, $CHU +4.4%, $WFC +2.9%, $PAC +2.8%, $CHL +2.4%, $ACMR +2.2%, $CLDT +2%, $MYGN +1.9%, $PRSC +1.8%, $AWH +1.6%, $AZN +1.1%, $FIX +1%, $FATE +1%, $GRBK +0.9%, $PROF +0.9%, $CHA +0.7%, $T +0.5%'"
2021-01-06,b'$FATE Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants https://t.co/Ex4Ehu6L6r'
2021-01-06,b'$CWPE Announced Engaging Global Investment Bank to Raise Capital to Expand Growth and Signed Agreement with Major Convenience Store Chain to Become Franchisee for Several Stores\nhttps://t.co/0Q3996iwcQ $OBLN $GTEC $ONCT $FATE $TNXP $CTRA $MP $TRNE $BRTXQ $INNO $IPIX $NWBO $CNGT'
2021-01-06,"b'Gapping up:\n$CHNG +37.7%, $CALM +8.2%, $CHU +4.4%, $WFC +2.9%, $PAC +2.8%, $CHL +2.4%, $ACMR +2.2%, $CLDT +2%, $MYGN +1.9%, $PRSC +1.8%, $AWH +1.6%, $AZN +1.1%, $FIX +1%, $FATE +1%,'"
2021-01-06,"b'Surprised that $FATE did offering with warrants attached , usually smaller cap stocks do warrants and fo course, SPACs'"
2021-01-06,b'RT @Briefingcom: $FATE: Fate Therapeutics prices offering of common stock and pre-funded warrants https://t.co/N3K927aPbJ'
2021-01-06,"b'Ten stocks, randomly selected: $TDAC $EFC-A $MDLY $BDSI $HBCP $NXR $SCCB $FATE $ITW $SAVE. More details at https://t.co/FOOriXawTk'"
2021-01-06,b'$FATE: Fate Therapeutics prices offering of common stock and pre-funded warrants https://t.co/N3K927aPbJ'
2021-01-06,b'Fate Therapeutics prices equity offering and pre-funded warrants $FATE https://t.co/MZxm7v05Qb'
2021-01-06,b'RT @TheStockWire: $FATE\nFate Therapeutics Priced 4.4M Share Public Offering of Common Stock @$85.50/Share'
2021-01-06,"b'RT @kevinjaybe: $FATE 4,421,053 shares @ $85.5 raising +- $400 million'"
2021-01-06,b'Fate Therapeutics 4.421M share Secondary priced at $85.50\n$FATE'
2021-01-06,b'RT @BioStocks: $FATE prices offering. 4.42M shares at $85.50/share.'
2021-01-06,b'$FATE prices offering. 4.42M shares at $85.50/share.'
2021-01-06,b'$FATE\nFate Therapeutics Priced 4.4M Share Public Offering of Common Stock @$85.50/Share'
